Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study page now indicates recruitment is closed to new participants and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention label formatting and notes Revision: v3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedRevision tag on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the entry. This change represents an internal version bump and does not modify the study details presented.SummaryDifference0.1%

- Check37 days agoChange DetectedThe revision label at the bottom of the page changed from v3.5.3 to v3.5.4, indicating a new page version. The visible study details and layout remain the same for users.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s build/revision label was updated from v3.5.2 to v3.5.3 without any visible change to the displayed study details.SummaryDifference0.1%

- Check65 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check94 days agoChange DetectedSite revision updated to v3.5.0; the previous v3.4.3 revision was removed.SummaryDifference0.1%

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.